C. Margini, L.B. (2014). Reinfusion of highly purified CD133+ stem cells in patients with end-stage liver disease (ESLD): final results of a phase I clinical trial [10.1016/j.dld.2014.01.019].
Reinfusion of highly purified CD133+ stem cells in patients with end-stage liver disease (ESLD): final results of a phase I clinical trial
L. BrodosiSecondo
Writing – Original Draft Preparation
;S. LorenziniConceptualization
;L. CataniMethodology
;D. SollazzoData Curation
;M. BaccaraniSupervision
;M. BernardiSupervision
;R. LemoliWriting – Review & Editing
;P. AndreoneUltimo
Writing – Review & Editing
2014
File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.